Pancreatic Cancer Research

ResearcherPhilipps University of MarburgActive in the last 2 years

Jörg Walter Bartsch

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-2773-3357; OpenAlex author ID A5033122338. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
28
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 3 papers

Papers 9

  1. Deciphering the regulatory role of ADAM8 in the PDAC tumor microenvironment. Last author DOI 10.1007/s13402-026-01266-7↗
  2. Emerging concepts, hot topics, and open questions in today's pancreatic cancer research. Co-author DOI 10.1016/j.bbcan.2026.189614↗
  3. Small-Molecule Activators of PRMT1: Discovery, SAR Analyses, and Proapoptotic Effects in Pancreatic Cancer Cells. Co-author DOI 10.1021/acs.jmedchem.5c03281↗
  4. The long non-coding RNA NEAT1 contributes to aberrant STAT3 signaling in pancreatic cancer and is regulated by a metalloprotease-disintegrin ADAM8/miR-181a-5p … Last author DOI 10.1007/s13402-024-01001-0↗
  5. Extracellular Vesicle-Based Detection of Pancreatic Cancer. Co-author DOI 10.3389/fcell.2021.697939↗
  6. Cohort Analysis of ADAM8 Expression in the PDAC Tumor Stroma. Last author DOI 10.3390/jpm11020113↗
  7. The Immune Microenvironment in Pancreatic Cancer. Co-author DOI 10.3390/ijms21197307↗
  8. ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/1878-0261.12426↗
  9. ADAM8 as a drug target in pancreatic cancer. Last author DOI 10.1038/ncomms7175↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Uta‐Maria Bauer · 4 shared papers, 2025–2026 · strength 0.96
  2. Matthias Lauth · 3 shared papers, 2020–2026 · strength 0.60
  3. Corinna Ulrike Keber · 2 shared papers, 2026 · strength 0.55
  4. Elke Pogge von Strandmann · 3 shared papers, 2020–2026 · strength 0.51
  5. Kimia Zandieh · 2 shared papers, 2025–2026 · strength 0.46
  6. Yutong Gao · 2 shared papers, 2025–2026 · strength 0.46
  7. Pietro Di Fazio · 2 shared papers, 2025–2026 · strength 0.46
  8. Detlef Klaus Bartsch · 3 shared papers, 2021–2025 · strength 0.45
  9. Magdalena Huber · 2 shared papers, 2020–2026 · strength 0.40
  10. Thomas Mathias Gress · 2 shared papers, 2020–2026 · strength 0.40
  11. Emily P. Slater · 3 shared papers, 2020–2021 · strength 0.36
  12. Malte Buchholz · 2 shared papers, 2020–2025 · strength 0.31
  13. Anna I. Brichkina · 1 shared paper, 2026 · strength 0.29
  14. Yesim Verel‐Yilmaz · 2 shared papers, 2021 · strength 0.25
  15. Christian Peter Jaworek · 2 shared papers, 2021 · strength 0.25
  16. Sepideh Salehipour-Bavarsad · 1 shared paper, 2026 · strength 0.21
  17. Xiangdi Yu · 1 shared paper, 2025 · strength 0.20
  18. Bilal Alashkar Alhamwe · 1 shared paper, 2020 · strength 0.11
  19. Christian Alexander Bauer · 1 shared paper, 2020 · strength 0.11
  20. Victor Oginga Oria · 1 shared paper, 2019 · strength 0.09
  21. Oliver Schilling · 1 shared paper, 2019 · strength 0.09
  22. Birte Kulemann · 1 shared paper, 2019 · strength 0.09
  23. Jens Hoeppner · 1 shared paper, 2019 · strength 0.09
  24. Uwe Schlomann · 1 shared paper, 2015 · strength 0.04
  25. Rozita Roshani · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.